Takeo Mukai
Chief Executive Officer bei ACUTUS MEDICAL, INC.
Vermögen: 13 700 $ am 31.03.2024
Profil
Takeo Mukai is currently the Chief Executive & Financial Officer at Acutus Medical, Inc. He previously worked as the Finance Director at Medtronic, Inc. from 2007 to 2021.
Mr. Mukai completed his undergraduate degree at Carnegie Mellon University in 2001 and obtained an MBA from USC Marshall School of Business in 2011.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ACUTUS MEDICAL, INC.
0,25% | 01.03.2024 | 72 874 ( 0,25% ) | 13 700 $ | 31.03.2024 |
Aktive Positionen von Takeo Mukai
| Unternehmen | Position | Beginn |
|---|---|---|
| ACUTUS MEDICAL, INC. | Chief Executive Officer | 08.01.2024 |
Ehemalige bekannte Positionen von Takeo Mukai
| Unternehmen | Position | Ende |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Director of Finance/CFO | 01.01.2021 |
Ausbildung von Takeo Mukai
| Carnegie Mellon University | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACUTUS MEDICAL, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
